FDA Points Toward More Openness, With Details TBA
This article was originally published in The Tan Sheet
Executive Summary
FDA's formation of an internal Transparency Task Force is a savvy approach that allows agency leaders to begin making good now on their pledges to enhance openness while giving them six months to decide whether to release any specific new information
You may also be interested in...
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products
Commissioner Hamburg: Moving FDA Beyond A Regulatory Agency
Of the leading candidates for FDA commissioner in the Obama administration, Margaret Hamburg seemed among those with the least relevant experience -- an illustrious career to be sure, but one that lacked a decision-making role involving medical products